Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serine-linked PARP1 auto-modification controls PARP inhibitor response
Evgeniia Prokhorova, Florian Zobel, Rebecca Smith, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 76

Showing 26-50 of 76 citing articles:

Positioning Loss of PARP1 Activity as the Central Toxic Event in BRCA-Deficient Cancer
Nathan J. MacGilvary, Sharon B. Cantor
DNA repair (2024) Vol. 144, pp. 103775-103775
Open Access | Times Cited: 4
Duplexed CeTEAM drug biosensors reveal determinants of PARP inhibitor selectivity in cells
Maria João Pires, Seher Alam, Alen Lovrić, et al.
Journal of Biological Chemistry (2025), pp. 108361-108361
Open Access
PARP inhibitors in ovarian cancer: mechanisms of resistance and implications to therapy
Sanat Kulkarni, N. Seneviratne, Çağla Tosun, et al.
DNA repair (2025), pp. 103830-103830
Open Access
Serine ADP-ribosylation in DNA-damage response regulation
Luca Palazzo, Marcin J. Suskiewicz, Ivan Ahel
Current Opinion in Genetics & Development (2021) Vol. 71, pp. 106-113
Open Access | Times Cited: 26
Slow Dissociation from the PARP1–HPF1 Complex Drives Inhibitor Potency
Petra Stojanovic, Karolin Luger, Johannes Rudolph
Biochemistry (2023) Vol. 62, Iss. 16, pp. 2382-2390
Open Access | Times Cited: 10
Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: Past, present, and future
Meng-Ling Hu, Yi-Ru Pan, Yuan-Yuan Yong, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102078-102078
Closed Access | Times Cited: 9
ADP-ribosylation, a multifaceted modification: Functions and mechanisms in aging and aging-related diseases
Wu Hao, Zhao Jialong, Yuan Jiuzhi, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102347-102347
Open Access | Times Cited: 3
The loss of DNA polymerase epsilon accessory subunits POLE3–POLE4 leads to BRCA1-independent PARP inhibitor sensitivity
Hasan Mamar, Roberta Fajka‐Boja, Mónika Mórocz, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 12, pp. 6994-7011
Open Access | Times Cited: 3
PARP1-dependent DNA-protein crosslink repair
Zita Fábián, Ellen S. Kakulidis, Ivo A. Hendriks, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities
Yosuke Yamada, Djeda Belharazem-Vitacolonnna, Hanibal Bohnenberger, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 14
The function and regulation of ADP-ribosylation in the DNA damage response
Lena Duma, Ivan Ahel
Biochemical Society Transactions (2023) Vol. 51, Iss. 3, pp. 995-1008
Open Access | Times Cited: 8
The interplay of TARG1 and PARG protects against genomic instability
Joséphine Groslambert, Evgeniia Prokhorova, Anne R. Wondisford, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113113-113113
Open Access | Times Cited: 8
The Making and Breaking of Serine-ADP-Ribosylation in the DNA Damage Response
Kira Schützenhofer, J.G.M. Rack, Ivan Ahel
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 18
Molecular and toxicological mechanisms behind the effects of chromium (VI) on the male reproductive system of Mytilus galloprovincialis: First evidence for poly-ADP-ribosylation of protamine-like II
Carmela Marinaro, Alberto Marino, Anna Rita Bianchi, et al.
Chemico-Biological Interactions (2024) Vol. 401, pp. 111186-111186
Open Access | Times Cited: 2
Biallelic ADPRHL2 mutations in complex neuropathy affect ADP ribosylation and DNA damage response
Danique Beijer, Thomas Agnew, J.G.M. Rack, et al.
Life Science Alliance (2021) Vol. 4, Iss. 11, pp. e202101057-e202101057
Open Access | Times Cited: 17
Temporal and Site-Specific ADP-Ribosylation Dynamics upon Different Genotoxic Stresses
Sara C. Buch-Larsen, Alexandra K.L.F.S. Rebak, Ivo A. Hendriks, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2927-2927
Open Access | Times Cited: 16
Dispensability of HPF1 for cellular removal of DNA single-strand breaks
Kristyna Hrychova, Kamila Burdová, Zuzana Polackova, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 18, pp. 10986-10998
Open Access | Times Cited: 2
New Methodologies to Study DNA Repair Processes in Space and Time Within Living Cells
Siham Zentout, Rebecca Smith, Marine Jacquier, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 15
Roles of DNA damage repair and precise targeted therapy in renal cancer (Review)
Yongchang Lai, Zhibiao Li, Zechao Lu, et al.
Oncology Reports (2022) Vol. 48, Iss. 6
Open Access | Times Cited: 10
The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitors
Adèle Beneyton, Louis Nonfoux, Jean‐Philippe Gagné, et al.
NAR Cancer (2023) Vol. 5, Iss. 3
Open Access | Times Cited: 6
Molecular basis of threonine ADP-ribosylation of ubiquitin by bacterial ARTs
Jiaxing Tan, Yan Xu, Xiaofei Wang, et al.
Nature Chemical Biology (2023) Vol. 20, Iss. 4, pp. 463-472
Closed Access | Times Cited: 6
The disruption of the CCDC6 – PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma
Francesco Morra, Francesco Merolla, Giovanna Damia, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 8
The HPF1-dependent histone PARylation catalyzed by PARP2 is specifically stimulated by an incised AP site-containing BER DNA intermediate
Tatyana A. Kurgina, Nina Moor, Mikhail M. Kutuzov, et al.
DNA repair (2022) Vol. 120, pp. 103423-103423
Closed Access | Times Cited: 8
PARP–nucleic acid interactions: Allosteric signaling, PARP inhibitor types, DNA bridges, and viral RNA surveillance
John M. Pascal
Current Opinion in Structural Biology (2023) Vol. 81, pp. 102643-102643
Open Access | Times Cited: 4
HTS discovery of PARP1-HPF1 complex inhibitors in cancer
Timothy Kellett, Rida Noor, Qiong Zhou, et al.
SLAS DISCOVERY (2023) Vol. 28, Iss. 8, pp. 394-401
Open Access | Times Cited: 4

Scroll to top